182 related articles for article (PubMed ID: 16156397)
1. Drug hypersensitivities: definition, epidemiology and risk factors.
Demoly P; Gomes ER
Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):202-6. PubMed ID: 16156397
[TBL] [Abstract][Full Text] [Related]
2. Classification and epidemiology of hypersensitivity drug reactions.
Demoly P; Hillaire-Buys D
Immunol Allergy Clin North Am; 2004 Aug; 24(3):345-56, v. PubMed ID: 15242715
[TBL] [Abstract][Full Text] [Related]
3. Immediate-type drug hypersensitivity and associated factors in a general population.
Kurt E; Demir AU; Cadirci O; Yildirim H; Pinar Eser T
Allergol Immunopathol (Madr); 2011; 39(1):27-31. PubMed ID: 20675031
[TBL] [Abstract][Full Text] [Related]
4. [Drug allergies: a public health problem].
Bousquet J; Demoly P; Hillaire-Buys D; Blayac JP; Godard P; Michel FB
Bull Acad Natl Med; 2000; 184(4):737-50. PubMed ID: 10989560
[TBL] [Abstract][Full Text] [Related]
5. Self-reported antibiotic allergy incidence and prevalence: age and sex effects.
Macy E; Poon K-Y T
Am J Med; 2009 Aug; 122(8):778.e1-7. PubMed ID: 19635279
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
[TBL] [Abstract][Full Text] [Related]
7. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children.
Lange L; Koningsbruggen SV; Rietschel E
Pediatr Allergy Immunol; 2008 Nov; 19(7):634-8. PubMed ID: 18221471
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of acute cutaneous drug reactions in a Scandinavian university hospital.
Borch JE; Andersen KE; Bindslev-Jensen C
Acta Derm Venereol; 2006; 86(6):518-22. PubMed ID: 17106599
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reactions and the autopsy. Prevalence and perspective.
Gotti EW
Arch Pathol; 1974 Apr; 97(4):201-4. PubMed ID: 4814703
[No Abstract] [Full Text] [Related]
10. [Drug allergy and hypersensitivity. Risk factors].
Demoly P; Guglielmi P; Guglielmi L
Bull Acad Natl Med; 2006 Nov; 190(8):1733-42; discussion 1742-4. PubMed ID: 17650756
[TBL] [Abstract][Full Text] [Related]
11. [Immunoallergic reactions of drug origin: epidemiologic and clinical data].
Demoly P; Messaad D; Benahmed S; Hillaire-Buys D; Blayac JP; Godard P; Michel FB; Bousquet J
Therapie; 2000; 55(1):13-9. PubMed ID: 10859996
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of hypersensitivity drug reactions.
Gomes ER; Demoly P
Curr Opin Allergy Clin Immunol; 2005 Aug; 5(4):309-16. PubMed ID: 15985812
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.
Kim BH; Bradley T; Tai J; Budman DR
Oncology; 2009; 76(4):231-8. PubMed ID: 19246947
[TBL] [Abstract][Full Text] [Related]
14. Allergic drug reactions. How to minimize the risks.
Bernstein JA
Postgrad Med; 1995 Aug; 98(2):159-60, 163-6. PubMed ID: 7630844
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population.
Borch JE; Andersen KE; Bindslev-Jensen C
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):357-62. PubMed ID: 16623858
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous adverse drug reactions seen at a university hospital department of dermatology.
Borch JE; Andersen KE; Bindslev-Jensen C
Acta Derm Venereol; 2006; 86(6):523-7. PubMed ID: 17106600
[TBL] [Abstract][Full Text] [Related]
17. Sex- and age-related differences in rabies immunoglobulin hypersensitivity.
Suwansrinon K; Jaijareonsup W; Wilde H; Benjavongkulchai M; Sriaroon C; Sitprija V
Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):206-8. PubMed ID: 16806332
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients.
Navo M; Kunthur A; Badell ML; Coffer LW; Markman M; Brown J; Smith JA
Gynecol Oncol; 2006 Nov; 103(2):608-13. PubMed ID: 16797060
[TBL] [Abstract][Full Text] [Related]
19. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population.
Dowling K; Storr CL; Chilcoat HD
Clin J Pain; 2006; 22(9):776-83. PubMed ID: 17057559
[TBL] [Abstract][Full Text] [Related]
20. [Allergy--triggers of life-threatening and fatal anaphylaxis].
Brockow K; Ring J
MMW Fortschr Med; 2006 Jul; 148(29-30):28-31. PubMed ID: 16910403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
